NCT03502785 2025-07-10
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Inovio Pharmaceuticals
Phase 1/2 Completed
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals